Is it or ain’t it “really” cancer?

In a new article in the Journal of Urology, researchers at Johns Hopkins Medical Center in Baltimore have again expressed their opinion that it would be inappropriate to rename low-risk Gleason 6 disease as something other than “cancer”. … READ MORE …

When is active surveillance not really active surveillance?

A story that got wide coverage yesterday (in the cancer-specific media, at least) said that “research published online in the Journal of Clinical Oncology suggests that ‘active surveillance for clinical stage I (CSI) testicular cancer leads to excellent outcomes’.” … READ MORE …

New terminology, IDLE threats, and human behavior (about cancer)

An article by Esserman et al. in the May issue of Lancet Oncology has again laid out the argument being made by a number of leading cancer specialists that “new terminology” is a necessary requirement for smarter discussions between all relevant parties about “indolent and precancerous disorders”. … READ MORE …

Two new terms needed in the management of advanced prostate cancer

It is rapidly becoming apparent that we are going to need two simple, new terms to be able to use in discussion of the evolution of progressive prostate cancer after “standard” forms of androgen deprivation therapy (ADT) have failed to work. So … anyone got good, scientifically sound suggestions? … READ MORE …